SWK Holdings Current Liabilities
Delisted
The Current Liabilities of SWK Holdings (SWKH) as of Nov 5, 2026 is 4.97 M USD. In the previous year, Current Liabilities was 4.07 M USD — a change of 22.36% (higher).
Get this data via API
Financial Data API
Current Liabilities
4.97 MUSD
YoY
22.36%
Last updated:
Current Liabilities of SWK Holdings is 2025 4.97 M USD. Current Liabilities of SWK Holdings was 2024 4.07 M USD. It decreases by 22.36% higher compared to the previous year.
The SWK Holdings Current Liabilities history
3 Years
10 Years
25 Years
Max
Current Liabilities
Date
Current Liabilities
Jan 1, 2018
2.59 M USD
Jan 1, 2019
17.56 M USD
Jan 1, 2020
11.36 M USD
Jan 1, 2021
5.10 M USD
Jan 1, 2022
6.31 M USD
Jan 1, 2023
3.94 M USD
Jan 1, 2024
4.07 M USD
Jan 1, 2025
4.97 M USD
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 4.97 MUSD | +22.36% | |
| 4.07 MUSD | +3.07% | |
| 3.94 MUSD | -37.54% | |
| 6.31 MUSD | +23.73% | |
| 5.10 MUSD | -55.07% | |
| 11.36 MUSD | -35.32% | |
| 17.56 MUSD | +577.51% | |
| 2.59 MUSD | -29.57% | |
| 3.68 MUSD | +169.79% | |
| 1.36 MUSD | +70.50% | |
| 800,000.00USD | -63.37% | |
| 2.18 MUSD | +249.44% | |
| 625,000.00USD | +434.19% | |
| 117,000.00USD | -69.77% | |
| 387,000.00USD | -10.21% | |
| 431,000.00USD | -26.32% | |
| 585,000.00USD | -97.54% | |
| 23.77 MUSD | +13.51% | |
| 20.94 MUSD | -15.34% | |
| 24.74 MUSD | -43.35% | |
| 43.67 MUSD | -28.76% | |
| 61.30 MUSD | +39.37% | |
| 43.98 MUSD | -16.06% | |
| 52.39 MUSD | -56.10% | |
| 119.33 MUSD | +28.89% | |
| 92.58 MUSD | +175.54% | |
| 33.60 MUSD | +833.33% | |
| 3.60 MUSD | +1,700.00% | |
| 200,000.00USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
SWK Holdings Stock analysis
What does SWK Holdings do? SWK Holdings Corp is a US-based company specializing in investments in growth-oriented life sciences companies. The company was founded in 1996 and is headquartered in Dallas, Texas. Its business model focuses on investing capital in companies developing innovative technologies in the life sciences field. SWK Holdings Corp supports its portfolio companies with capital and resources to promote their growth and development. The company offers a wide range of products and services, including financing and investment services, business development, and consulting. It focuses on financing companies in various areas, including biotechnology, medical devices, and pharmaceuticals. SWK Holdings Corp specializes in various segments within the life sciences field, including cancer, autoimmune diseases, dermatology, ophthalmology, neurology, orthopedics, and cardiology. It also invests in companies developing therapeutics and diagnostics for rare diseases. Over the years, SWK Holdings Corp has gained a strong reputation in the industry through its investments in a variety of companies and technologies. The company is known for its ability to quickly and flexibly respond to changing market trends and conditions. It takes pride in being a responsible company that adheres to ethical business practices and supports the community and environmental protection. SWK Holdings Corp also strives to find opportunities to reduce its ecological footprint. In summary, SWK Holdings Corp is a US-based company specializing in investments in growth-oriented life sciences companies. The company has a reputation for its ability to quickly and flexibly respond to changing market trends and conditions. It offers a wide range of products and services and specializes in various segments within the life sciences field. SWK Holdings Corp is a responsible company committed to adhering to ethical business practices and supporting the community and environmental protection. SWK Holdings is one of the most popular companies on Eulerpool.
Frequently Asked Questions about SWK Holdings stock
Current Liabilities of SWK Holdings is 4.97 M USD in 2025.
Current Liabilities of SWK Holdings changed from 4.07 M USD to 4.97 M USD, representing a 22.36% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities SWK Holdings since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's SWK Holdings historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — SWK Holdings
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — SWK Holdings
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth